Catalio Capital Management, LP
•CIK: 1958125•Filing: Q4 2025
**Catalio Capital Management, LP** manages $566M across a portfolio of 45 positions, exhibiting a concentrated focus on the healthcare sector. Top holdings include GILD at $35.5M and BMY at $34.9M, anchoring significant exposure to pharmaceutical and biotech names. The fund maintains substantial allocations to industry leaders such as BSX ($34.4M), BBOT ($31.4M), and LLY ($27.9M). This positioning suggests a deep, conviction-driven approach within the life sciences value chain.
Total AUM
$565.8M
QoQ Performance
+4.6%
Positions
45
Top 10 Concentration
51.2%
Latest Filing
Q4 2025
Top Holdings Allocation
GILD
BMY
BSX
BBOT
GILD6.3%
BMY6.2%
BSX6.1%
BBOT5.6%
LLY4.9%
DNTH4.8%
ASND4.5%
SNDX4.4%
📈 Biggest Buys
📉 Biggest Sells
Sector Breakdown
Other78.2%
Healthcare21.8%
🚪 Exited Positionssold since Q3 2025
+2 more exited positions
Changes from Q3 2025
NEW14 new positions
↑5 increased
↓20 decreased
Historical Filings
Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024